Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
Karkinos is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer.
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Aims to become India’s leading cancer testing company
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
Construction of the plant will commence in 2025 with first production expected to be in 2027
_256_384.jpg)
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
Revenue at Rs 3,623 crore, EBITDA at Rs 718 crore
Subscribe To Our Newsletter & Stay Updated
